PNLIP and obesity due to melanocortin 4 receptor deficiency: Although there are emerging evidence to suggest DPA may possess unique physiological actions including anti-platelet aggregation, pancreatic lipase inhibition and potential anti-obesity effects, its efficacy in affording direct cardio-protection has not been evaluated to date using pre-formed and more pure forms of the fatty acid.